Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis
- 18 March 2024
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (10) , 8361-8386
Abstract
The purinergic signaling system comprises a complex network of extracellular purines and purine-metabolizing ectoenzymes, nucleotide and nucleoside receptors, ATP release channels, and nucleoside transporters. Because of its immunomodulatory function, this system is critically involved in the pathogenesis of multiple sclerosis (MS) and its best-characterized animal model, experimental autoimmune encephalomyelitis (EAE). MS is a chronic neuroinflammatory demyelinating and neurodegenerative disease with autoimmune etiology and great heterogeneity, mostly affecting young adults and leading to permanent disability. In MS/EAE, alterations were detected in almost all components of the purinergic signaling system in both peripheral immune cells and central nervous system (CNS) glial cells, which play an important role in the pathogenesis of the disease. A decrease in extracellular ATP levels and an increase in its downstream metabolites, particularly adenosine and inosine, were frequently observed at MS, indicating a shift in metabolism toward an anti-inflammatory environment. Accordingly, upregulation of the major ectonucleotidase tandem CD39/CD73 was detected in the blood cells and CNS of relapsing–remitting MS patients. Based on the postulated role of A2A receptors in the transition from acute to chronic neuroinflammation, the association of variants of the adenosine deaminase gene with the severity of MS, and the beneficial effects of inosine treatment in EAE, the adenosinergic system emerged as a promising target in neuroinflammation. More recently, several publications have identified ADP-dependent P2Y12 receptors and the major extracellular ADP producing enzyme nucleoside triphosphate diphosphohydrolase 2 (NTPDase2) as novel potential targets in MS.Keywords
Funding Information
- Ministarstvo Nauke, Tehnološkog Razvoja i Inovacija (451-03-47/2023-01/ 200178, 451-03-47/2023-01/200007)
This publication has 298 references indexed in Scilit:
- Expression of functionally distinct ecto‐5′‐nucleotidase/CD73 glycovariants in reactive astrocytes in experimental autoimmune encephalomyelitis and neuroinflammatory conditions in vitroGlia, 2023
- P2Y12 antagonism results in altered interactions between platelets and regulatory T cells during sepsisJournal of Leukocyte Biology, 2020
- Compartment‐specific metabolomics for CHO reveals that ATP pools in mitochondria are much lower than in cytosolBiotechnology Journal, 2015
- P2X4 receptors control the fate and survival of activated microgliaGlia, 2013
- The medial habenula contains a specific nonstellate subtype of astrocyte expressing the ectonucleotidase NTPDase2Glia, 2012
- Association of the ecto‐ATPase NTPDase2 with glial cells of the peripheral nervous systemGlia, 2003
- Selective expression of Gi/o‐coupled ATP receptor P2Y12 in microglia in rat brainGlia, 2003
- Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosisAnnals of Neurology, 2001
- Expression of purine metabolism-related enzymes by microglial cells in the developing rat brainJournal of Comparative Neurology, 1998
- In vitro differentiation of neural progenitor cells from prenatal rat brain: Common cell surface glycoprotein on three glial cell subsetsJournal of Neuroscience Research, 1997